Acamprosate: a new tool in the battle against alcohol dependence
- PMID: 19412493
- PMCID: PMC2671951
- DOI: 10.2147/nedt.2006.2.4.445
Acamprosate: a new tool in the battle against alcohol dependence
Abstract
Acamprosate, a medication that has been used in Europe for years, is the newest drug to be approved by the US Federal Drug Administration for the treatment of alcohol dependence. It has been shown to assist in the maintenance of abstinence in recently detoxified alcohol-dependent individuals. The following review delineates the proposed mechanism of action and pharmacokinetics of the drug. Findings of clinical trials are outlined and topics such as cost effectiveness, comparison with other medications used for the treatment of alcohol dependences as well as combination pharmacotherapy are discussed. In combination with psychosocial treatment, acamprosate is a promising tool for the maintenance of abstinence in alcohol-dependent patients after alcohol withdrawal. This review also illustrates the continued need to search for more effective treatments, as the overall effectiveness of our currently available pharmacotherapies remains limited in the long-term maintenance of recovery from alcohol dependence.
Keywords: abstinence; acamprosate; alcohol; alcohol dependence.
Similar articles
-
Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility.Ther Clin Risk Manag. 2012;8:45-53. doi: 10.2147/TCRM.S23184. Epub 2012 Feb 1. Ther Clin Risk Manag. 2012. PMID: 22346357 Free PMC article.
-
Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.Drugs. 1997 Jun;53(6):1038-53. doi: 10.2165/00003495-199753060-00008. Drugs. 1997. PMID: 9179530 Review.
-
Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.CNS Drugs. 2005;19(5):445-64. doi: 10.2165/00023210-200519050-00006. CNS Drugs. 2005. PMID: 15907154 Review.
-
Pharmacotherapy of alcohol dependence: a review of the clinical data.CNS Drugs. 2004;18(8):485-504. doi: 10.2165/00023210-200418080-00002. CNS Drugs. 2004. PMID: 15182219 Review.
-
Acamprosate: A Review of Its Use in Alcohol Dependence.Drugs. 2015 Jul;75(11):1255-68. doi: 10.1007/s40265-015-0423-9. Drugs. 2015. PMID: 26084940 Review.
Cited by
-
Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility.Ther Clin Risk Manag. 2012;8:45-53. doi: 10.2147/TCRM.S23184. Epub 2012 Feb 1. Ther Clin Risk Manag. 2012. PMID: 22346357 Free PMC article.
-
The Role of Taurine in Mitochondria Health: More Than Just an Antioxidant.Molecules. 2021 Aug 13;26(16):4913. doi: 10.3390/molecules26164913. Molecules. 2021. PMID: 34443494 Free PMC article. Review.
References
-
- Anonymous Acamprosate (Campral) for alcoholism. Med Lett Drugs Ther. 2005;47:1–3. - PubMed
-
- [APA] American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
-
- Bachteler D, Economidou D, Danysz W, et al. The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat. Neuropsychopharmacology. 2005;30:1104–10. - PubMed
-
- Besson J, Aeby F, Kasas A, et al. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alcohol Clin Exp Res. 1998;22:573–9. - PubMed
-
- Boeijinga PH, Parot P, Soufflet L, et al. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence. Neuropsychobiology. 2004;50:71–7. - PubMed
LinkOut - more resources
Full Text Sources